Repeated Intranasal Esketamine Plus Almond Therapy in Participants With Treatment Resistant Depressive Disorder - 3 Month Extension Study

NCT05438758 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Withdrawn by Sponsor

Conditions

Treatment Resistant Major Depressive Disorder

Interventions

BEHAVIORAL: Almond Therapy
DRUG: Intranasal ketamine (Esketamine)
BEHAVIORAL: Treatment as Usual

Sponsor

Zylorion Health